Interpace Biosciences Inc (STU:PF42)
€ 2.32 -0.14 (-5.69%) Market Cap: 11.03 Mil Enterprise Value: 15.96 Mil PE Ratio: 2.40 PB Ratio: 0 GF Score: 39/100

Q3 2019 Interpace Diagnostics Group Inc Earnings Call Transcript

Nov 13, 2019 / 09:30PM GMT
Release Date Price: €7.05 (+9.30%)
Operator

Greetings, and welcome to the Interpace Biosciences Third Quarter 2019 Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

During this call, the company will make forward-looking statements. We caution you that any statement that is not a statement of historical fact is a forward-looking statement. This includes remarks about the company's financial projections, expectations, plans, beliefs and prospects. These statements are based on judgment and analysis as of the date of the conference call and are subject to numerous important risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.

These risks and uncertainties associated with the forward-looking statements made in this conference call are described in the safe harbor statement in today's earnings release as well as Interpace Biosciences' public periodic filings, including the discussion of Risk Factors section in our Form 10-K filed with the SEC on March 21, 2019, the risk factors set forth on Form 8-K filed with the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot